Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) FCF Margin (2016 - 2025)

iBio (IBIO) has disclosed FCF Margin for 16 consecutive years, with 5697.0% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin changed N/A to 5697.0% in Q3 2025 year-over-year; TTM through Dec 2025 was 6389.67%, a 203793.0% decrease, with the full-year FY2025 number at 3829.0%, up 451056.0% from a year prior.
  • FCF Margin was 5697.0% for Q3 2025 at iBio, down from 2306.0% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 366.0% in Q1 2022 to a low of 12464.29% in Q3 2021.
  • A 5-year average of 4381.3% and a median of 2306.0% in 2025 define the central range for FCF Margin.
  • Biggest YoY gain for FCF Margin was 292517bps in 2021; the steepest drop was -1063770bps in 2021.
  • iBio's FCF Margin stood at 12464.29% in 2021, then skyrocketed by 97bps to 366.0% in 2022, then crashed by -2818bps to 10680.0% in 2023, then soared by 82bps to 1950.5% in 2024, then crashed by -192bps to 5697.0% in 2025.
  • Per Business Quant, the three most recent readings for IBIO's FCF Margin are 5697.0% (Q3 2025), 2306.0% (Q2 2025), and 1950.5% (Q4 2024).